Home / Drug shortages / Hydromorphone Hydrochloride Injection

Hydromorphone Hydrochloride Injection — FDA Drug Shortage

Current — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Hydromorphone Hydrochloride Injection (injection) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 11/01/2017.

Shortage Details

Status
Current
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0703-0018-01
Dosage Form
Injection
Presentation
Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01)
Initial Posting
11/01/2017
Revised Date

FDA data resources